Radiopaedia Helpers

Strong List Colon Position

error

"T1: iso- to hypointense compared to the optic nerve or grey matter"

Line 80:8 · When enboldening an intro, the colon should not be bold. 'T1: iso'

"T2: iso- to hyperintense compared to the optic nerve or grey matter"

Line 81:8 · When enboldening an intro, the colon should not be bold. 'T2: iso'

"T1 C+ (Gd): homogeneous enhancement"

Line 82:8 · When enboldening an intro, the colon should not be bold. 'T1 C+ (Gd): homogeneous'

"DWI/ADC: may have diffusion restriction ¹³"

Line 83:8 · When enboldening an intro, the colon should not be bold. 'DWI/ADC: may'

Isotope Notation

error

"On somatostatin receptor PET-CT (e.g. ⁶⁸Ga-DOTATOC, ⁶⁸Ga-DOTATATE, or ⁶⁸Ga-DOTANOC), optic nerve sheath meningiomas often have high uptake, due to high somatostatin receptor 2A (SSTR2A) expression ¹⁴."

Line 87:54 · Write the isotope as symbol-mass, e.g. F-18, not '68Ga'.

"On somatostatin receptor PET-CT (e.g. ⁶⁸Ga-DOTATOC, ⁶⁸Ga-DOTATATE, or ⁶⁸Ga-DOTANOC), optic nerve sheath meningiomas often have high uptake, due to high somatostatin receptor 2A (SSTR2A) expression ¹⁴."

Line 87:82 · Write the isotope as symbol-mass, e.g. F-18, not '68Ga'.

"On somatostatin receptor PET-CT (e.g. ⁶⁸Ga-DOTATOC, ⁶⁸Ga-DOTATATE, or ⁶⁸Ga-DOTANOC), optic nerve sheath meningiomas often have high uptake, due to high somatostatin receptor 2A (SSTR2A) expression ¹⁴."

Line 87:115 · Write the isotope as symbol-mass, e.g. F-18, not '68Ga'.

EG List And

warning

"On somatostatin receptor PET-CT (e.g. ⁶⁸Ga-DOTATOC, ⁶⁸Ga-DOTATATE, or ⁶⁸Ga-DOTANOC), optic nerve sheath meningiomas often have high uptake, due to high somatostatin receptor 2A (SSTR2A) expression ¹⁴."

Line 87:44 · An e.g. list gives selected examples, so it should not end with 'and' or 'or': 'e.g. 68Ga-DOTATOC, 68Ga-DOTATATE, or'.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Complications"

Line 110:1 · "Complications" is under the wrong parent heading (found under "Treatment and prognosis").

Semicolons

suggestion

"Optic nerve sheath meningiomas account for approximately 1-2% of all meningiomas ¹¹, and a third of all optic nerve neoplasms; optic nerve gliomas are the most common entity. Unlike optic nerve gliomas which occur primarily in children, optic nerve sheath meningiomas are usually seen in adults (mean age at presentation 40 years) ^1,5, however up to 25% are present in children, in which case they tend to be more aggressive ⁵. Similar to meningiomas elsewhere there is a female predilection ^1,11."

Line 4:147 · Use semicolons judiciously.

"stereotactic fractionated radiotherapy (SFRT) or intensity-modulated radiotherapy (IMRT) are preferred to conventional radiotherapy ^7,11; proton beam radiotherapy and stereotactic radiosurgery may other options ^8,11"

Line 96:155 · Use semicolons judiciously.

Oxford Comma

suggestion

"rarely indicated, often reserved for cases with severely impaired vision, with or without severe proptosis, or if there is imaging evidence of posterior growth threatening the contralateral optic nerve ¹¹"

Line 104:74 · Use the Oxford comma in 'vision, with or without'.

Lint: optic-nerve-sheath-meningioma